Free Trial

Sionna Therapeutics (NASDAQ:SION) Shares Gap Up - Here's What Happened

Sionna Therapeutics logo with Medical background
Remove Ads

Shares of Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $13.88, but opened at $14.18. Sionna Therapeutics shares last traded at $13.87, with a volume of 4,394 shares trading hands.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. TD Cowen began coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They set a "buy" rating for the company. Stifel Nicolaus initiated coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a "buy" rating and a $32.00 target price for the company. Finally, Guggenheim assumed coverage on Sionna Therapeutics in a report on Tuesday, March 4th. They set a "buy" rating and a $45.00 price target on the stock.

View Our Latest Research Report on SION

Sionna Therapeutics Stock Performance

Sionna Therapeutics (NASDAQ:SION - Get Free Report) last released its quarterly earnings results on Thursday, March 20th. The company reported ($3.38) EPS for the quarter, missing analysts' consensus estimates of ($2.68) by ($0.70).

About Sionna Therapeutics

(Get Free Report)

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.

Featured Stories

Should You Invest $1,000 in Sionna Therapeutics Right Now?

Before you consider Sionna Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sionna Therapeutics wasn't on the list.

While Sionna Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads